Dr. Ray Page, DO, PhD of the Center for Cancer and Blood Disorders (Texas Cancer Center) was joined by EMOL Health Leadership the 2024 World Conference on Lung Cancer in San Diego. They jointly presented their results from a year long program that was implemented to improve the effective testing rates for EGFR in mNSCLC patients. This program is similar to other Clinical Decision Support systems that EMOL Health has created. The abstractEffective EGFR Testing Rates in Advanced Stage NSCLC Patients Treated in Community Oncology Practices: Impact of a Decision Support Program (2024-RA-678-WCLC) is available here
